Enveric Biosciences (NASDAQ: ENVB)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Enveric Biosciences (NASDAQ: ENVB) through any online brokerage.
The latest price target for Enveric Biosciences (NASDAQ: ENVB) was reported by Aegis Capital on Tuesday, March 8, 2022. The analyst firm set a price target for 0.20 expecting ENVB to rise to within 12 months (a possible 2.62% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Enveric Biosciences (NASDAQ: ENVB) is $0.1949 last updated Today at May 25, 2022, 1:36 PM UTC.
There are no upcoming dividends for Enveric Biosciences.
Enveric Biosciences’s Q2 earnings are confirmed for Friday, August 12, 2022.
There is no upcoming split for Enveric Biosciences.
Enveric Biosciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.